Osteopore Limited (OSX.AX)

0.0950 -0.0250 (-20.83%) At close: 03:02PM AEST

Osteopore Limited

2 Tukang Innovation Grove
No. 09-06/07 MedTech Hub JTC MedTech Hub
Singapore 618305
Singapore

https://www.osteopore.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kei Wei Leong	Executive Chairman	150k	N/A	1976
Dr. Jing Lim	CEO & CTO	202.25k	N/A	N/A
Ms. Kellie Davis	Joint Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Osteopore Limited engages in the design, development, and marketing of bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. The company has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

Corporate governance

Osteopore Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.